M. Aiach, M. Alhenc-gelas, D. Borgel, J. Emmerich, S. Gandrille et al., Mutations des prot??ines de la coagulation et thromboses, m??decine/sciences, vol.22, issue.11, pp.985-994, 2006.
DOI : 10.1051/medsci/20062211985

E. Oger and . Group, Groupe d'Etude de la Thrombose de Bretagne Occidentale. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study, Thromb Haemost, vol.83, issue.5, pp.657-60, 2000.
URL : https://hal.archives-ouvertes.fr/hal-00726218

V. Olié, F. Chin, A. Lamarche-vadel, D. Peretti, and C. , La maladie veineuse thromboembolique??: patients hospitalis??s et mortalit?? en France en 2010, Journal des Maladies Vasculaires, vol.38, issue.5, pp.33-34417, 2013.
DOI : 10.1016/j.jmv.2013.07.040

G. Plu-bureau, M. Horellou, A. Gompel, and J. Conard, Contraception hormonale et risque thromboembolique veineux??: quand demander une ??tude de l???h??mostase??? Et laquelle???, Gyn??cologie Obst??trique & Fertilit??, vol.36, issue.4, pp.448-454, 2008.
DOI : 10.1016/j.gyobfe.2008.02.006

J. E. Dalen and J. S. Alpert, Natural history of pulmonary embolism Prog, Cardiovasc. Dis, vol.17, pp.159-170, 1975.

J. A. Parakos, S. J. Aldestein, H. Smit, and R. E. Coll, Late Prognosis of Acute Pulmonary Embolism, New England Journal of Medicine, vol.289, issue.2, pp.55-58, 1973.
DOI : 10.1056/NEJM197307122890201

I. Naess, S. Christiansen, P. Romundstad, S. Cannegieter, F. Rosendaal et al., Incidence and mortality of venous thrombosis: a population-based study, Journal of Thrombosis and Haemostasis, vol.34, issue.4, pp.692-701, 2007.
DOI : 10.1056/NEJM200012213432504

W. Ageno, C. Becattini, T. Brighton, R. Selby, and P. Kamphuisen, Cardiovascular Risk Factors and Venous Thromboembolism: A Meta-Analysis, Circulation, vol.117, issue.1, pp.93-102, 2008.
DOI : 10.1161/CIRCULATIONAHA.107.709204

M. Severinsen, . Overvadk, S. Johnsen, C. Dethlefsen, P. Madse et al., Genetic susceptibility, smoking, obesity and risk of venous thromboembolism, British Journal of Haematology, vol.12, issue.2, pp.273-279, 2010.
DOI : 10.1111/j.1365-2141.2010.08086.x

P. Leger, D. Barcat, C. Boccalon, J. Guilloux, and H. Boccalon, Thrombose veineuse des membres inférieurs et de la veine cave inférieure, Encycl Med Chirg, vol.2004, pp.80-96

G. Zhang, X. Xu, W. Su, and Q. Xu, Smoking and risk of venous thromboembolism : a systematc review. Southeast Asian J Trop Med Public HEalth, pp.736-781, 2014.

P. Stein, A. Beemath, and R. Olson, Obesity as a risk factor in venous thromboembolism, The American Journal of Medicine, vol.118, issue.9, pp.978-980, 2005.
DOI : 10.1016/j.amjmed.2005.03.012

R. Pomp, S. Le-cessie, F. Rosendaal, and C. Doggen, Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations, British Journal of Haematology, vol.19, issue.2, pp.289-296, 2007.
DOI : 10.1056/NEJM200012143432403

J. Souto, L. Almasy, M. Borrell, F. Blanco-vaca, M. J. Soria et al., Genetic Susceptibility to Thrombosis and Its Relationship to Physiological Risk Factors: The GAIT Study, The American Journal of Human Genetics, vol.67, issue.6, pp.1452-1459, 2000.
DOI : 10.1086/316903

T. Larsen, H. Sörensen, A. Skytthe, S. Johnsen, J. Vaupel et al., Major Genetic Susceptibility for Venous Thromboembolism in Men: A Study of Danish Twins, Epidemiology, vol.14, issue.3, pp.328-332, 2003.
DOI : 10.1097/01.EDE.0000060457.51194.BC

B. Zöller, X. Li, J. Sundquist, and K. Sundquist, Age- and Gender-Specific Familial Risks for Venous Thromboembolism: A Nationwide Epidemiological Study Based on Hospitalizations in Sweden, Circulation, vol.124, issue.9, pp.1012-1032, 2011.
DOI : 10.1161/CIRCULATIONAHA.110.965020

F. Couturaud, C. Leroyer, J. Julian, S. Kahn, J. Ginsberg et al., Factors That Predict Risk of Thrombosis in Relatives of Patients With Unprovoked Venous Thromboembolism, Chest, vol.136, issue.6, pp.1537-1582, 2009.
DOI : 10.1378/chest.09-0757

URL : https://hal.archives-ouvertes.fr/hal-00683296

D. Fabio, F. Lykoudis, P. Gordon, and P. , Thromboembolism in Inflammatory Bowel Disease: An Insidious Association Requiring a High Degree of Vigilance, Seminars in Thrombosis and Hemostasis, vol.37, issue.03, pp.220-225, 2011.
DOI : 10.1055/s-0031-1273086

M. Holmqvist, M. Neovius, and J. Eriksson, Risk of Venous Thromboembolism in Patients With Rheumatoid Arthritis and Association With Disease Duration and Hospitalization, JAMA, vol.308, issue.13, pp.1350-1356, 2012.
DOI : 10.1001/2012.jama.11741

N. Isma, J. Merlo, H. Ohlsson, P. J. Svensson, B. Lindblad et al., Socioeconomic factors and concomitant diseases are related to the risk for venous thromboembolism during long time follow-up, Journal of Thrombosis and Thrombolysis, vol.241, issue.5, pp.58-64, 2013.
DOI : 10.1007/s11239-012-0858-8

H. Decousus, P. Frappé, S. Accassat, L. Bertoletti, and A. Buchmuller, Epidemiology, diagnosis, treatment and management of superficial-vein thrombosis of the legs, Best Practice & Research Clinical Haematology, vol.25, issue.3, pp.275-284, 2012.
DOI : 10.1016/j.beha.2012.07.005

K. Van-langevelde, W. M. Lijfering, F. Rosendaal, and S. C. Cannegieter, Increased risk of venous thrombosis in persons with clinically diagnosed superficial vein thrombosis: results from the MEGA study, Blood, vol.118, issue.15, pp.118-133, 2011.
DOI : 10.1182/blood-2011-05-356071

R. Roach, W. Lijfering, V. H. Vlieg, A. Helmerhorst, F. Rosendaal et al., The risk of venous thrombosis in individuals with a history of superficial vein thrombosis and acquired venous thrombotic risk factors, Blood, vol.122, issue.26, pp.122-148, 2013.
DOI : 10.1182/blood-2013-07-518159

C. Karathanos, G. Sfyroeras, A. Drakou, N. Roussas, M. Exarchou et al., Superficial Vein Thrombosis in Patients with Varicose Veins: Role of Thrombophilia Factors, Age and Body Mass, European Journal of Vascular and Endovascular Surgery, vol.43, issue.3, pp.355-358, 2012.
DOI : 10.1016/j.ejvs.2011.12.019

P. Hanson, J. Sorbo, and H. Eriksson, Recurrent Venous Thromboembolism After Deep Vein Thrombosis, Archives of Internal Medicine, vol.160, issue.6, pp.769-74, 2000.
DOI : 10.1001/archinte.160.6.769

H. Janssen, J. Schachner, J. Hubbard, and J. Hartman, The risk of deep vein thrombosis : a computerized epidemiologic approach, Surgery, vol.101, pp.205-217, 1987.

B. Bjornara and D. Gudmundsente, Frequency and timing of clinical venous thromboembolism after major joint surgery, Journal of Bone and Joint Surgery - British Volume, vol.88, issue.3, pp.386-391, 2006.
DOI : 10.1302/0301-620X.88B3.17207

R. White, H. Zhou, and P. Romano, Incidence of symptomatic venous thromboembolismafter different electiveorurgent surgical procedures, ThrombHae-most, vol.90, pp.367-368, 2003.

L. Lapidus, S. Ponzer, H. Pettersson, and E. Bri, Symptomatic venous thromboembolism and mortality in orthopaedic surgery ??? an observational study of 45 968 consecutive procedures, BMC Musculoskeletal Disorders, vol.108, issue.Suppl 6, p.177, 2013.
DOI : 10.1378/chest.108.4.978

C. Samama, B. Gafsou, T. Jeandel, S. Laporte, A. Steib et al., Prévention de la maladie thromboembolique veineuse postopératoire. Actualisation Texte court. Annales Françaises d'Anesthésie et de, ca05_24.htm 33-Pernod G, et al. Recommandations pour la recherche de facteurs biologiques de risque dans le cadre de la maladie thromboembolique veineuse: applications cliniques, pp.947-951, 2009.

F. Rosendaal, Venous thromboembosis : the roles of genes, environnment, and behavior, Hematology Am Soc Hematol Educ Program, pp.1-12, 2005.

D. Chandra, E. Parisini, and D. Mozaffarian, Meta-analysis: Travel and Risk for Venous Thromboembolism, Annals of Internal Medicine, vol.151, issue.3, pp.180-190, 2009.
DOI : 10.7326/0003-4819-151-3-200908040-00129

F. Chleir, Maladie thromboembolique des voyages a??riens, EMC - Ang??iologie, vol.7, issue.1, pp.1-5, 2012.
DOI : 10.1016/S1290-0176(12)49702-2

F. Rosendaal, Venous thrombosis: a multicausal disease, The Lancet, vol.353, issue.9159, pp.1167-73, 1999.
DOI : 10.1016/S0140-6736(98)10266-0

O. Egeberg, Inherited antithrombin deficiency causing thrombophilia, Thromb Diath Haemorr, vol.13, pp.516-546, 1965.

J. Griffin, B. Evatt, and T. Zimmerman, Deficiency of protein C in congenital thrombotic disease., Journal of Clinical Investigation, vol.68, issue.5, pp.1370-1373, 1981.
DOI : 10.1172/JCI110385

P. Comp, R. Nixon, M. Cooper, and C. Esmon, Familial protein S deficiency is associated with recurrent thrombosis., Journal of Clinical Investigation, vol.74, issue.6, pp.2082-2090, 1984.
DOI : 10.1172/JCI111632

C. Vossen, J. Conard, and J. Fontcuberta, Familial thrombophilia and lifetime risk of venous thrombosis, Journal of Thrombosis and Haemostasis, vol.89, issue.9, pp.1526-1558, 2004.
DOI : 10.1111/j.1538-7836.2004.00852.x

C. Vossen, J. Conard, and J. Fontcuberta, Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT), Journal of Thrombosis and Haemostasis, vol.135, issue.3, pp.459-64, 2005.
DOI : 10.1016/S0140-6736(96)01109-9

P. Ridker, J. Miletich, C. Hennekens, and J. Buring, Ethnic Distribution of Factor V Leiden in 4047 Men and Women, JAMA, vol.277, issue.16, p.1305, 1997.
DOI : 10.1001/jama.1997.03540400055031

A. Blanco-molina, J. Trujillo-santos, and R. Tirado, Venous thromboembolism in women using hormonal contraceptives. Findings from the RIETE Registry, Thrombosis and Haemostasis, vol.101, pp.478-482, 2009.
DOI : 10.1160/TH08-10-0684

URL : https://hal.archives-ouvertes.fr/ujm-00439719

J. Vandenbroucke, T. Koster, and E. Briet, Increased risk of venous thrombosis in oralcontraceptive users who are carriersof factor V Leiden mutation, Lancet, vol.334, pp.1453-1457, 1994.

O. Wu, L. Robertson, and P. Langhorne, Oral contraceptives, hormone remplacement therapy, thrombophilias and risk of venous thromboembolism : a systematic review. The thrombosis : risk and economic assessment of thrombophilia screening (TREATS) Study, Thromb Haemost, vol.94, pp.17-25, 2005.

B. Raccah-tebeka and G. Plu-bureau, La contraception en pratique, de la situation clinique à la prescription, 2013.

K. Bloemenkamp, F. Rosendaal, F. Helmerhorst, and J. Vandenbroucke, Higher Risk of Venous Thrombosis During Early Use of Oral Contraceptives in Women With Inherited Clotting Defects, Archives of Internal Medicine, vol.160, issue.1, pp.49-52, 2000.
DOI : 10.1001/archinte.160.1.49

C. Lockwood, R. Romero, R. Feinberg, L. Clyne, B. Coster et al., The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. American journal of obstetrics and gynecology, pp.369-73, 1989.

A. El-roeiy and N. Gleicher, Definition of normal autoantibody levels in an apparently healthy population. Obstetrics and gynecology, pp.596-602, 1988.

E. Somers, W. Marder, P. Cagnoli, E. Lewis, P. Deguire et al., Population-Based Incidence and Prevalence of Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program, Arthritis & Rheumatology, vol.46, issue.2, pp.369-78, 2014.
DOI : 10.1002/art.38238

Q. Reynaud, J. Lega, P. Mismetti, C. Chapelle, D. Wahl et al., Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: A systematic review and meta-analysis, Autoimmunity Reviews, vol.13, issue.6, pp.595-608, 2014.
DOI : 10.1016/j.autrev.2013.11.004

K. Choojitarom, O. Verasertniyom, K. Totemchokchyakarn, K. Nantiruj, V. Sumethkul et al., Lupus nephritis and Raynaud???s phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies, Clinical Rheumatology, vol.91, issue.3, pp.345-51, 2008.
DOI : 10.1007/s10067-007-0721-z

S. Malresse, T. Drevillon, T. Swebel, M. Horellou, J. Conard et al., Homocystéine et maladie veineuse thromboembolique : la fin d'une belle histoire ?, STV, vol.22, pp.144-153, 2010.

M. Alhenc-gelas, E. Arnaud, V. Nicaud, M. Aubry, J. Fiessinger et al., Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes. Thrombosis and haemostasis, pp.506-516, 1999.

J. Kemmeren, A. Algra, and D. Grobbee, Third generation oral contraceptives and risk of venous thromboembolism, BMJ, vol.323, pp.1-9, 2001.

P. Bureau, G. Maitrot-mantelet, L. Hugon-rodin, J. Canonico, and M. , Hormonal contraceptives and venous thromboembolism: An epidemiological update, Best Practice & Research Clinical Endocrinology & Metabolism, vol.27, issue.1, pp.25-34, 2013.
DOI : 10.1016/j.beem.2012.11.002

M. Abdollahi, M. Cushman, and F. Rosendaal, Obesity: risk of venous thrombosis and the interaction with coagulation factorslevels and oral contraceptive use, Thrombosis and Haemostasis, vol.89, pp.493-498, 2003.

V. Odlind, I. Milsom, I. Persson, and A. Victor, Can changes in sex hormone bindingglobulin predict the risk of venous thromboembolism with combiend oral contraceptive pill ?, Acta Obstet Gynecol Scand, vol.81, pp.482-490, 2002.

J. Hugon-rodin, A. Gompel, and G. Plu-bureau, MECHANISMS IN ENDOCRINOLOGY: Epidemiology of hormonal contraceptives-related venous thromboembolism, European Journal of Endocrinology, vol.171, issue.6, pp.14-0527, 2014.
DOI : 10.1530/EJE-14-0527

S. Tchaikoski and J. Rosing, Mechanisms of Estrogen-Induced Venous Thromboembolism, Thrombosis Research, vol.126, issue.1, pp.5-11, 2010.
DOI : 10.1016/j.thromres.2010.01.045

O. Lidegaard, L. Nielsen, C. Skovlund, F. Skjeldestad, and E. Lokkegaard, Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses : Danish cohort study, BMJ, vol.343, pp.2001-2010, 2011.

R. Herings, J. Urquhart, and H. Leufkens, Venous thromboembolism amng new users of different oral contraceptives., The Lancet, vol.354, issue.9173, pp.127-128, 1999.
DOI : 10.1016/S0140-6736(99)01257-X

. Van-hylckama, A. Vlieg, F. Helmerhorst, and J. Vandenbroucke, The venous thrombotic risk of oral contraceptives, effectsof oestrogen dose and progestogen type: results of the MEGA casecontrol study, British Medical Journal, vol.339, 2009.

B. Stegeman, M. De-bastos, and F. Rosendaal, Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis, BMJ, vol.347, issue.sep12 1, p.5298, 2013.
DOI : 10.1136/bmj.f5298

J. Kemmeren, A. Algra, and D. Grobbee, Third génération oral contraceptives and risk of venous thromboembolism, BMJ, vol.323, pp.1-9, 2001.

M. Martínez, I. Ramírez, and E. Pérez-campos, Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis. The European Journal of Contraception and Reproductive Health Care, pp.7-29, 2012.

T. Meade, G. Greenberg, and S. Thompson, Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations., BMJ, vol.280, issue.6224, pp.1157-1161, 1980.
DOI : 10.1136/bmj.280.6224.1157

A. Van-hylckama-vlieg and S. Middeldorp, Hormone therapies and venous thromboembolism: where are we now?, Journal of Thrombosis and Haemostasis, vol.84, issue.Suppl. 6, pp.257-266, 2011.
DOI : 10.1111/j.1538-7836.2010.04148.x

M. Alhenc-gelas, G. Plu-bureau, and S. Guillonneau, Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives, Journal of Thrombosis and Haemostasis, vol.103, issue.Suppl. 1, pp.1594-1600, 2004.
DOI : 10.1111/j.1538-7836.2004.00894.x

M. Raps, F. Helmerhorst, and K. Fleischer, Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives, Journal of Thrombosis and Haemostasis, vol.877, issue.6, pp.992-997, 2012.
DOI : 10.1111/j.1538-7836.2012.04720.x

C. Klipping, I. Duijkers, S. Parke, U. Mellinger, M. Serrani et al., Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive, Drugs in R&D, vol.4, issue.Suppl.2, pp.159-170, 2011.
DOI : 10.2165/11591200-000000000-00000

M. Ågren, M. Anttila, K. Mäenpä-Ä-liukko, M. Rantala, R. Hilkka et al., Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17??-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism, The European Journal of Contraception & Reproductive Health Care, vol.81, issue.4, pp.444-457, 2011.
DOI : 10.1016/j.contraception.2005.09.015

R. Sitruk-ware, G. Plu-bureau, and J. Menard, Effects of Oral and Transvaginal Ethinyl Estradiol on Hemostatic Factors and Hepatic Proteins in a Randomized, Crossover Study, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.6, pp.2074-2079, 2007.
DOI : 10.1210/jc.2007-0026

K. Fleischer, H. Van-vliet, and F. Rosendaal, Effects of the contraceptive patch, the vaginal ring and an oral contraceptiveon APC resistance and SHBG: a cross-over study, Thrombosis Research, vol.3, pp.429-435, 2009.

C. Kluft, P. Meijer, and K. Laguardia, Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables, Contraception, vol.77, issue.2, pp.77-83, 2008.
DOI : 10.1016/j.contraception.2007.10.004

D. Grimes, L. Lopez, O. Brien, and P. , Progestin-only pills for contraception, Cochrane Database of Systemic Review, issue.1, p.7541, 2010.
DOI : 10.1002/14651858.cd007541.pub2

A. Bergandal, V. Odlind, and I. Persson, Limited knowledge on progestogen-only contraception and risk of venous thromboembolism, Acta Obstetricia et Gynecologica Scandinavica, vol.88, issue.3, pp.261-266, 2009.
DOI : 10.1080/00016340902730375

M. Blanco-molina, M. Lozano, and A. Cano, Progestin-only contraception and venous thromboembolism, Thrombosis Research, vol.129, issue.5, pp.257-262, 2012.
DOI : 10.1016/j.thromres.2012.02.042

S. Mantha, R. Karp, V. Raghavan, N. Terrin, K. A. Bauer et al., Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis, BMJ, vol.345, issue.aug07 2, p.4944, 2012.
DOI : 10.1136/bmj.e4944

H. Vaillant-roussel, L. Ouchchane, and C. Dauphin, Risk factors for recurrence of venous thromboembolism associated with the use of oral contraceptives, Contraception, vol.84, issue.5, pp.23-30, 2011.
DOI : 10.1016/j.contraception.2011.06.008

O. Lidegaard, L. Hougaard-nielsen, and C. Wessel-skovlund, Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10, BMJ, vol.344, issue.may10 3, p.2990, 2001.
DOI : 10.1136/bmj.e2990

J. Conard, G. Plu-bureau, N. Bahia, M. Horellou, C. Pelissier et al., Progestogen-only contraception in women at high risk of venous thromboembolism, Contraception, vol.70, issue.6, pp.437-441, 2004.
DOI : 10.1016/j.contraception.2004.07.009

N. Chabbert-buffet, Z. Amoura, and P. Scarabin, Pregnane progestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patients, Contraception, vol.83, issue.3, pp.229-237, 2011.
DOI : 10.1016/j.contraception.2010.08.012

M. Canonico, E. Oger, and G. Plu-bureau, Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens: The ESTHER Study, Circulation, vol.115, issue.7, pp.840-845, 2007.
DOI : 10.1161/CIRCULATIONAHA.106.642280

URL : https://hal.archives-ouvertes.fr/hal-00688234

R. Klemetti, T. Sevón, M. Gissler, and E. Hemminki, Complications of IVF and ovulation induction, Human Reproduction, vol.20, issue.12, pp.3293-300, 2005.
DOI : 10.1093/humrep/dei253

W. Chan, The ???ART??? of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology, Current Opinion in Obstetrics and Gynecology, vol.21, issue.3, pp.207-225, 2009.
DOI : 10.1097/GCO.0b013e328329c2b8

K. Rova, H. Passmark, G. Pelle, and . Lindqvist, Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles, Fertility and sterility, pp.15-02823600, 2012.

P. Henriksson, E. Westerlund, and . Håkanwallén, Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study, BMJ, vol.346, issue.jan15 3, p.8632, 2013.
DOI : 10.1136/bmj.e8632

J. Heit, C. Kobbervig, A. James, T. Petterson, K. Bailey et al., Trends in the Incidence of Venous Thromboembolism during Pregnancy or Postpartum: A 30-Year Population-Based Study, Annals of Internal Medicine, vol.143, issue.10, pp.697-706, 2005.
DOI : 10.7326/0003-4819-143-10-200511150-00006

A. James, M. Jamison, L. Brancazio, and E. Myers, Venous thromboembolism during pregnancy and the postpartum period: Incidence, risk factors, and mortality, American Journal of Obstetrics and Gynecology, vol.194, issue.5, pp.1311-1316, 2006.
DOI : 10.1016/j.ajog.2005.11.008

K. Brenner, Hemostatic changes in pregnancy, Thromb res, pp.114-409, 2003.

S. Eichinger, A. Weltermann, K. Philipp, E. Hafner, A. Kaider et al., Prospective evaluation of hemostatic system activation and thrombin potential, Thromb Haemost, vol.82, issue.4, pp.1232-1236, 1999.

P. Marik and L. Plante, Venous Thromboembolic Disease and Pregnancy, New England Journal of Medicine, vol.359, issue.19, pp.2025-2058, 2008.
DOI : 10.1056/NEJMra0707993

P. Clark, S. Twaddle, I. Walker, L. Scott, I. Greer et al., Cost-effectiveness of screening for the factor V Leiden mutation in pregnant women Venous Thromboembolic Disease and Pregnancy Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study Deep vein thrombosis during pregnancy and the puerperium: a metaanalysis of the period of risk and leg of presentation 104- Hooman Kamel, Babak B. Navi, Nandita Sriram. Risk of a Thrombotic Event after the 6- Week Postpartum Period 105- Bonnar J. Can more be done in obstetric and gynecologic practice to reduce morbidity and mortality associated with venous thromboembolism? 106- Greer IA. Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology, Monreal M, Prandoni P. Venous thromboembolism as first manifestation of cancer, pp.1919-1939, 1997.

S. Laporte, B. Tardy, S. Quenet, A. Buchmüller-cordier, S. Chabaud et al., The location od deep vein thrombosis as a predictive factor for recurrence and cancer discovery after proximal deep-vein thrombosis Are venous thromboembolic events associated with subsequent breast and colorectal carcinoma diagnoses in the elderly ? A case control study of Medicare beneficiaries, Haematologica Cancer, vol.88106, pp.923-953, 2003.

M. Levine, J. Hirsh, and M. Gent, Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer, The Lancet, vol.343, issue.8902, pp.886-889, 1994.
DOI : 10.1016/S0140-6736(94)90008-6

P. Anderson, D. Bormanis, J. Guy, F. Mitchell, M. Grey et al., Evaluation of d-dimer in the diagnostis of suspected deep-vein thrombosis quoi de neuf ? Réanimation Deep-vein thrombosis N 116- http://www.armvop.fr/wp/?p=3401 117- http://www.has-sante.fr/portail/jcms/c_1369193/fr/contraception-fiches-memo 118- http D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for the first idiopathic deep vein thrombosis D-dimer levels and risk of recuurent venous thromboembolism 122- Paul A. Kyrle. Venous thrombosis: who should be screened for thrombophilia in 2014 The family history and inherited thrombophilia The value of family history as a risk indicator for venous thrombosis, Thromb Haemost Thromb Haemost N Engl J Med Engl. J. Med. Thromb Res JAMA Pol Arch Med Wewn. Br J Haematol. Arch Intern Med, vol.758134929087169, issue.123, pp.251-253, 1994.

L. Cam-duchez, V. Bagan-triquenot, A. Ménard, J. Mihout, B. Borg et al., Association of the protein C promoter CG haplotype and the factor II G20210A mutation is a risk factor cerebral venous thrombosis Role of ABO blood group and of other risk factors on the presence of residual vein obtsruction after deep-vein thrombosis Effects of prothrombotic markers and non-O blood group in maternal venous thromboembolism during pregnancy and postpartum Venous thromboembolism in young female while on oral contraceptives : hight frequency of inherited thrombophilia and analysis of thrombotic events in 400 czech women PP. The risk of oral contracetives in the etiology on inflammatory bowel disease : a meta-analysis, Thèse pour l'obtention du diplôme d'état de doctorat en médecine Echecs répétés de fécondations in vitro, anomalies retrouvées au bilan diagnostic. 131- Cornish JA 132- Schmidt PM, Cornu P, Angelillo-Scherrer A. Bases physiopathologiques en hématologie générale, pp.495-500, 2005.